Granting of partially refundable aid for the development of a new quarterly formulation of Risperidone


No votes yet
 
Related
ROVI holds its 2021 General Shareholders Meeting
Laboratorios Farmaceuticos Rovi, SA has held its today General Ordinary Shareholders Meeting, in which a valuation of the 2020 financial...
6 min
17/06/2021
During their visit to the facilities, they have been accompanied by the CEO of ROVI, Juan López-Belmonte; the vice president and CFO,...
2 min
14/05/2021